Multiple cell-surface proteins, e.g., CD133 (also known as PROM1), CD166, or CD44, have been proposed to identify distinct subsets of human colorectal CSCs, likely linking the TME with intracellular cancer-driver pathways. Here, PROM1 is linked to cancer.